Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2812631000168110 | Nalgestic Ultra (curcumin 12.148 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2812641000168118 | Nalgestic Ultra 12.148 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nalgestic Ultra 12.148 mg tablet | Is a | Nalgestic Ultra | true | Inferred relationship | Some | ||
| Nalgestic Ultra 12.148 mg tablet | Is a | curcumin 12.148 mg tablet | true | Inferred relationship | Some | ||
| Nalgestic Ultra 12.148 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Nalgestic Ultra 12.148 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Nalgestic Ultra 12.148 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 88163701 | |
| Nalgestic Ultra 12.148 mg tablet | has Australian BoSS | curcumin | true | Inferred relationship | Some | 88163700 | |
| Nalgestic Ultra 12.148 mg tablet | has intended active ingredient | curcumin | true | Inferred relationship | Some | 88163700 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nalgestic Ultra 12.148 mg tablet, 30 | has TPUU | True | Nalgestic Ultra 12.148 mg tablet | Inferred relationship | Some | 1 |
| Nalgestic Ultra 12.148 mg tablet, 30, bottle | has TPUU | True | Nalgestic Ultra 12.148 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR